Biofourmis Valuation Analysis: Latest Market Insights & Trends

Hill Chart Shape

Biofourmis Valuation and Overview

Biofourmis
Sectors
Health, BioTech, Hardware, Analytics
Headquarters
Boston, MA, USA
CEO
Maulik Majmudar, Renika Seghal, Milan Shah,, Daniel Song, Jaydev Thakkar
Biofourmis shares, as of April 21, 2025, are valued at a price per share implying an approximate +37.23% relative to the most recent significant secondary market activity in March 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Biofourmis's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Biofourmis.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX

Business Partnerships

Targeted Impact

Who Will Benefit?

What Comes Next?

Biofourmis Growth Timeline

No items found.

Biofourmis and Competition

For additional insights and information on Biofourmis, contact us today to access the full ApeVue report.
Request the full report

Biofourmis Market Inteligence Snapshot

Biofourmis Annual Revenue & Year-Over-Year Growth Rate

Biofourmis Secondary Market ROI (Return on Investment)

Biofourmis shares, as of April 21, 2025, are valued at a price per share implying an approximate +37.23% relative to the most recent significant secondary market activity in March 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Biofourmis's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Biofourmis.

Biofourmis Bid-Ask Volume Ratios (Private Secondary Market)

Biofourmis Mutual Fund Valuations (NAV)

Biofourmis Funding Rounds & Cap Table Details

Register today to view the full report, with more in-depth details and analytics:
Access the full report

Biofourmis VC / Strategic Investors

Biofourmis Research

No items found.

Biofourmis News

No items found.
Register today to view the full Biofourmis report, with more in-depth details and analytics:
Access the full Biofourmis report

Ready to see it in action?

Schedule a demo with one of our experts